David J. Blyweiss, MD began his medical career as a clinical pharmacist in South Florida prior to earning his medical degree from St. George's University School of Medicine in 1982. This dual background allowed him to appreciate the relevance of conventional pharmaceutical/surgical based treatments in acute medical conditions, but also to recognize where these approaches fell short in treating the majority of patients who suffered from the chronic degenerative diseases of "western civilization origin".
Over the last twenty years, with the nutritional medical knowledge base expanding in the fields of nutrigenomics, proteomics and other related "orthomolecular" disciplines directed towards patients' biochemical individuality, Dr. Blyweiss became an early adherent and experienced practitioner of what would become known as "functional medicine". Dr. Blyweiss has used this matrix of systems biology to effectively manage and alleviate the symptoms related to the most "difficult-to-treat" conditions by addressing the underlying causes, allowing the body to heal itself.
Dr. Blyweiss was one of the researchers doing the early work on chlorhexidine (phisohex) while earning his first post graduate degree at Temple University School of Pharmacy. During medical school he worked with the WHO (World Health Organization) in vaccinating children in the islands of the Caribbean. He has traveled the world, most recently to Gabon and Croatia working closely with teams of specialists to identify new plant life and natural products for possible human benefit. He has consulted for and created state-of-the -art nutritional supplements for multiple nutritional companies since 1999.His most recent accomplishment was forming Eden Laboratories Ltd. doing stem cell research and transplants in Belize, CA. He is currently in private practice in South Florida where he resides with his family.